Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Pathobiology is Scopus-indexed (Q1, CiteScore 4.9), WoS SCIE. Published by S. Karger AG.
Checked against the index lists dated .
ISSN 1015-2008Verify ISSN ↗1423-0291Verify ISSN ↗
Publisher: S. Karger AG
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pathology and Forensic Medicine | 52 / 209 | 75th | Q1 |
| Molecular Biology | 232 / 414 | 44th | Q3 |
| Cell Biology | 179 / 289 | 38th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1938–present, best quartile Q1, CiteScore 4.9.
Pathobiology is Q1 in Pathology and Forensic Medicine (rank 52 of 209), Q3 in Molecular Biology (rank 232 of 414) and Q3 in Cell Biology (rank 179 of 289), by CiteScore 2025.
Pathobiology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.9, which places it in quartile Q1 at the 75th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.716, quartile Q2, with an H-index of 67.
Pathobiology is published by S. Karger AG. Its print ISSN is 1015-2008 and its online ISSN is 1423-0291.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Pathobiology has an h-index of 78 and a 2-year mean of 1.5 citations per paper (OpenAlex). Its Scopus CiteScore is 4.9, quartile Q1. On 2-year citations it ranks #83 of 208 Scopus journals in Pathology and Forensic Medicine.
Pathobiology published 37 papers in 2025; its busiest recent year was 2020 with 67. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2023–2026), authors are most often from Japan (14.2%), South Korea (11%) and United States (10.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (1.1 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.